| Q28394513 | A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue |
| Q49949879 | Access to the CNS: Biomarker Strategies for Dopaminergic Treatments |
| Q35726276 | Acetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathway |
| Q37725116 | Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders. |
| Q41788377 | Amphetamine elevates phosphorylation of eukaryotic initiation factor 2α (eIF2α) in the rat forebrain via activating dopamine D1 and D2 receptors |
| Q90680251 | Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects |
| Q39789571 | Antipsychotic-induced catalepsy is attenuated in mice lacking the M4 muscarinic acetylcholine receptor. |
| Q38302762 | Brain tissue responses to neural implants impact signal sensitivity and intervention strategies. |
| Q41915908 | Centrality of striatal cholinergic transmission in Basal Ganglia function. |
| Q28471822 | Cholinergic interneurons are differentially distributed in the human striatum |
| Q37346316 | Comparison of the brain penetration injury associated with microdialysis and voltammetry |
| Q33756951 | Convergent evidence for abnormal striatal synaptic plasticity in dystonia |
| Q49645236 | Differential regulation of striatal motor behavior and related cellular responses by dopamine D2L and D2S isoforms |
| Q21134725 | Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2 |
| Q35030514 | Dopamine-galanin receptor heteromers modulate cholinergic neurotransmission in the rat ventral hippocampus. |
| Q54956878 | Dopamine-mediated calcium channel regulation in synaptic suppression in L. stagnalis interneurons. |
| Q43850191 | Dual cholinergic control of fast-spiking interneurons in the neostriatum. |
| Q89503681 | Effect of Dopamine D2 Receptor Antagonists on [18F]-FEOBV Binding |
| Q30472919 | Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission |
| Q43907020 | Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. |
| Q89707422 | Heterogeneity in striatal dopamine circuits: Form and function in dynamic reward seeking |
| Q47854859 | Integrated regulation of AMPA glutamate receptor phosphorylation in the striatum by dopamine and acetylcholine |
| Q33303267 | Motor deficits and altered striatal gene expression in aphakia (ak) mice |
| Q33770416 | Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents. |
| Q41831385 | Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons |
| Q33572429 | Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats |
| Q42488644 | Possible mechanisms of the involvement of dopaminergic cells and cholinergic interneurons in the striatum in the conditioned-reflex selection of motor activity |
| Q37014100 | Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission |
| Q34768885 | Repeated exposure to methamphetamine causes long-lasting presynaptic corticostriatal depression that is renormalized with drug readministration |
| Q36456003 | Restoration of amphetamine-induced locomotor sensitization in dopamine D1 receptor-deficient mice |
| Q37592449 | Restructuring of basal ganglia circuitry and associated behaviors triggered by low striatal D2 receptor expression: implications for substance use disorders. |
| Q42510692 | Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia. |
| Q42445572 | Substantia nigra D1 receptors and stimulation of striatal cholinergic interneurons by dopamine: a proposed circuit mechanism |
| Q64264112 | The Effects of Amphetamine and Methamphetamine on the Release of Norepinephrine, Dopamine and Acetylcholine From the Brainstem Reticular Formation |
| Q21131063 | The dopamine d1-d2 receptor heteromer in striatal medium spiny neurons: evidence for a third distinct neuronal pathway in Basal Ganglia |
| Q46630823 | Tolerance to the procholinergic action of the D1 receptor full agonist dihydrexidine |
| Q48965515 | Visual-induced excitation leads to firing pauses in striatal cholinergic interneurons. |
| Q39774300 | [11C]AF150(S), an agonist PET ligand for M1 muscarinic acetylcholine receptors |